Myopia

This year, Healio covered several studies and updates about treatment options to slow myopia progression, including one about a model developed to predict the onset of myopia.

Low-level red light therapy was superior to orthokeratology lenses at slowing myopia progression in children in the first year of treatment, though the difference was not significant in the second year, according to study results.

NEW YORK — In this Healio Video Perspective from OSN New York, George O. Waring IV, MD, FACS, discusses the benefits of the EVO ICL from STAAR Surgical.

Private investment firms Kian Capital Partners and RF Investment Partners announced the formation of US VisionMed Partners, a management services organization supporting medically focused optometry practices, according to a press release.

Over the course of the past decades, our IOL technology has continued to improve, particularly with the ability to address presbyopia.

NEW YORK — In this Healio Video Perspective from OSN New York, William B. Trattler, MD, of the Center for Excellence in Eye Care in Miami, discusses how the EVO ICL may be beneficial for patients with keratoconus and myopia.

Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is not meeting its primary endpoint of a less than 0.50 D progression in visual acuity over 3 years, according to a press release.

INDIANAPOLIS — To better manage patients with myopia, optometrists must understand normal myopia progression and axial elongation, as well as trends in treatment efficacy, according to a speaker at Academy 2024.

INDIANAPOLIS — CooperVision hosted an event at Academy 2024 celebrating the fifth anniversary of MiSight’s FDA approval, which was marked by patient success stories and real-world efficacy data.

Ocumetra, an optometric data analytics and software company, has partnered with Topcon Healthcare to enhance digital health care solutions for myopia management and improve eye care outcomes for children.